Product Images Rosuvastatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Rosuvastatin NDC 68071-3847 by Nucare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 3847 2
This is information related to a medication package containing Rosuvastatin 20mg tablets manufactured by uCare Pharmaceuticals, Inc. The package includes details such as NDC numbers, lot numbers, expiration date, and tablet specifications. It also provides a warning to keep the medication out of reach of children and store it at a controlled temperature between 68-77°F. It is important to consult a doctor for medical advice and report any side effects to the FDA.*
Figure-01 - figure 1
This appears to be statistical data related to a study or clinical trial comparing the effects of a treatment (RSV) versus a control (Placebo) on a certain outcome. The data includes information such as the number at risk over a specific duration of time for both groups. The text mentions confidence interval, statistical significance, and the number of subjects at each time point. The study may involve evaluating the impact or effectiveness of the RSV treatment compared to a placebo.*
Figure-02 - figure 2
This text presents a statistical comparison between the effects of Rosuvastatin (20 mg) and Placebo (20 mg) on various cardiovascular events in a total of 8901 patients. The study includes data on primary endpoints (MCE), cardiovascular death, non-fatal stroke, non-fatal MI, hospitalized unstable angina, and arterial revascularization. The hazard ratio (HR) along with confidence intervals and p-values are provided for each event, showing significant benefits of Rosuvastatin in reducing cardiovascular risk compared to Placebo. The results suggest Rosuvastatin may be effective in lowering the risk of cardiovascular events such as stroke, heart attack, and arterial revascularization.*
Figure-02 - figure 3
structural formula - rosuvastatin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
